文献速递瘢痕与激光

青蒿琥酯通过靶向IRE1α/XBP1信号通路并降低TGF-β1抑制瘢痕疙瘩成纤维细胞增殖

Inhibition of keloid fibroblast proliferation by artesunate is mediated by targeting the IRE1α/XBP1 signaling pathway and decreasing TGF-β1.
PubMed 文献 · Burns · 2024-03-05

该研究在体外培养人瘢痕疙瘩成纤维细胞(KFs)中检测IRE1α/XBP1通路及TGF-β1表达,通过转染干扰IRE1及青蒿琥酯处理观察细胞增殖与周期变化。结果显示该通路在KFs中激活,干扰IRE1α可抑制TGF-β1表达并影响细胞活力与周期;青蒿琥酯显著抑制增殖并使细胞周期阻滞于G1期,上调IRE1α后青蒿琥酯仍显示抑制作用。

要点

  • IRE1α/XBP1通路在瘢痕疙瘩成纤维细胞中激活,干扰IRE1α可抑制TGF-β1表达并影响细胞活力与周期。
  • 青蒿琥酯处理使瘢痕疙瘩成纤维细胞增殖显著降低,细胞周期阻滞于G1期。
  • 上调IRE1α后青蒿琥酯仍抑制细胞周期与增殖,相关蛋白表达受抑。

核心结论

  • IRE1α/XBP1通路在瘢痕疙瘩中激活,抑制该通路表达可影响细胞增殖活性。
  • 青蒿琥酯对成纤维细胞增殖有显著抑制作用,IRE1α/XBP1通路可能参与该过程。
  • 作者认为IRE1α/XBP1信号通路可能成为瘢痕治疗的潜在靶点,青蒿琥酯也可能成为瘢痕疙瘩治疗的有力候选药物。

研究设计与样本

  • 体外研究:培养人瘢痕疙瘩成纤维细胞(KFs),采用免疫组化检测XBP1与TGF-β1表达。
  • 通过细胞转染干扰IRE1表达,采用MTS、集落形成实验和流式细胞术评估对细胞增殖与细胞周期的影响。
  • 采用qRT-PCR和Western blot检测XBP1与TGF-β1表达。
  • 对部分细胞施加青蒿琥酯处理,用相同方法检测其对细胞活力及相关蛋白表达的影响。

主要发现

  • IRE1α/XBP1通路在KFs中激活。
  • 敲除IRE1α基因可抑制TGF-β1表达,并显著影响KFs的细胞活力与细胞周期进程。
  • 青蒿琥酯处理后细胞增殖显著降低,KFs细胞周期阻滞于G1期。
  • 上调IRE1α表达后再用青蒿琥酯处理KFs,细胞周期与增殖均显示受抑,相关蛋白表达也受抑。

临床怎么用

  • 作者认为IRE1α/XBP1信号通路可能成为瘢痕治疗的潜在靶点。
  • 作者认为青蒿琥酯也可能成为瘢痕疙瘩治疗的有力候选药物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Keloid is a benign hyperplastic dermatosis with high recurrence rate and complex pathogenesis. There is no universally effective treatment yet. New therapies and elucidation of pathogenesis are urgently required. AIMS: To explore the function of IRE1α/XBP1 in keloid fibroblasts and to investigate the potential mechanism of artesunate in inhibiting keloid hyperplasia. METHODS: Human keloid fibroblasts (KFs) were cultured, and the expressions of XBP1 and TGF-β1 were detected by immunohistochemistry. The expression of IRE1 was interfered with through cell transfection and the effects of IRE1 interference on cell proliferation and the cell cycle were assessed using MTS, colony formation assays, and flow cytometry. Detection of the expressions of XBP1 and TGF-β1 by qRT-PCR and Western blot. Then artesunate was applied to a subset of the cells, and its effects on cell viability and the expression of related proteins using the same methods. RESULTS: The IRE1α/XBP1 pathway was activated in KFs. Knocking out the gene IRE1α can inhibit the expression of TGF-β1, in addition, the cell viability and cell cycle progression of KFs were also significantly affected. After artesunate treatment, there was a remarkable reduction in cell proliferation. Meanwhile, the cell cycle of KFs treated with artesunate was blocked in G1 phase.After upregulating the expression of IRE1α and treating KFs with artesunate, both cell cycle and proliferation showed inhibitory effects, and related proteins also exhibited suppressed expression. CONCLUSIONS: The IRE1α/XBP1 pathway is activated in keloid, and inhibiting the expression of this pathway can affect the cell proliferation activity. In addition, artesunate also has a significant effect on fibroblast proliferation, and the IRE1α/XBP1 pathway may participate in this process. These findings suggest that IRE1α/XBP1 signal pathway may be a potential target for scar treatment, and artesunate could also be a powerful candidate for keloid treatment.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Han X, Jiang S, Hu C, et al. Inhibition of keloid fibroblast proliferation by artesunate is mediated by targeting the IRE1α/XBP1 signaling pathway and decreasing TGF-β1. Burns. 2024. PMID: 38492983. doi:10.1016/j.burns.2024.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。